GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » UFP Technologies Inc (NAS:UFPT) » Definitions » Cash Ratio

UFP Technologies (UFP Technologies) Cash Ratio : 0.22 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is UFP Technologies Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. UFP Technologies's Cash Ratio for the quarter that ended in Mar. 2024 was 0.22.

UFP Technologies has a Cash Ratio of 0.22. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for UFP Technologies's Cash Ratio or its related term are showing as below:

UFPT' s Cash Ratio Range Over the Past 10 Years
Min: 0.08   Med: 0.92   Max: 3.82
Current: 0.22

During the past 13 years, UFP Technologies's highest Cash Ratio was 3.82. The lowest was 0.08. And the median was 0.92.

UFPT's Cash Ratio is ranked worse than
83.51% of 855 companies
in the Medical Devices & Instruments industry
Industry Median: 1.23 vs UFPT: 0.22

UFP Technologies Cash Ratio Historical Data

The historical data trend for UFP Technologies's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UFP Technologies Cash Ratio Chart

UFP Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 1.60 0.29 0.08 0.09

UFP Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.10 0.11 0.09 0.22

Competitive Comparison of UFP Technologies's Cash Ratio

For the Medical Devices subindustry, UFP Technologies's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UFP Technologies's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, UFP Technologies's Cash Ratio distribution charts can be found below:

* The bar in red indicates where UFP Technologies's Cash Ratio falls into.



UFP Technologies Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

UFP Technologies's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=5.263/58.209
=0.09

UFP Technologies's Cash Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash Ratio (Q: Mar. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=11.372/52.436
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


UFP Technologies  (NAS:UFPT) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


UFP Technologies Cash Ratio Related Terms

Thank you for viewing the detailed overview of UFP Technologies's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


UFP Technologies (UFP Technologies) Business Description

Traded in Other Exchanges
Address
100 Hale Street, Newburyport, MA, USA, 01950-3504
UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products and packaging utilizing highly specialized foams, films, and plastics primarily for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
Executives
R Jeffrey Bailly director, 10 percent owner, officer: President and CEO 100 HALE STREET, NEWBURYPORT MA 01950
Mitchell Rock officer: Vice President C/O UFP TECHNOLOGIES, INC., 172 EAST MAIN STREET, GEORGETOWN MA 01833
Jason Holt officer: Vice President 100 HALE STREET, NEWBURYPORT MA 01950
Symeria Hudson director 100 HALE STREET, NEWBURYPORT MA 01950
Joseph Hassett director ONE TECHNOLOGY WAY, NORWOOD MA 02062
Daniel C Croteau director C/O LYNCH, BREWER, HOFFMAN & FINK, LLP, 75 FEDERAL STREET, 7TH FLOOR, BOSTON MA 02110
Cynthia L Feldmann director 17 WINTHROP ROAD, WAYLAND MA 01778
Christopher P. Litterio officer: Senior Vice President C/O UFP TECHNOLOGIES, INC., 100 HALE STREET, NEWBURYPORT MA 02143
Ronald J Lataille officer: Chief Financial Officer
Thomas Oberdorf director C/O GETTY IMAGES, INC., 601 N 34TH ST, SEATTLE WA 98103
Marc D Kozin director
Steve Cardin officer: Vice President 100 HALE STREET, NEWBURYPORT MA 01950
Daniel J Shaw officer: Vice President
W David Smith officer: Vice President 172 EAST MAIN STREET, GEORGETOWN MA 01833
Pierce Robert W Jr director C/O UFP TECHNOLOGIES, INC., 172 EAST MAIN STREET, GEORGETOWN MA 01833